Literature DB >> 9352706

Retrograde embolization and causes of failure in the primary treatment of varicocele.

M R Feneley1, M K Pal, I B Nockler, W F Hendry.   

Abstract

OBJECTIVE: To assess retrograde embolization for the treatment of varicocele and to examine the causes of surgical and radiological treatment failure. PATIENTS AND METHODS: Of 154 patients with clinical varicocele associated with subfertility or symptoms who were treated, 100 underwent surgical high ligation, retrograde embolization under fluoroscopic control was attempted in 84 and 30 had both forms of treatment. Venographic findings were defined in those patients for whom embolization proved impossible and in those in whom prior high ligation had failed. Among subfertile patients, 64 had semen analyses before and at least 3 months after the procedure available for comparison. Those patients undergoing both radiological and surgical procedures were sent questionnaires to evaluate their experience.
RESULTS: Retrograde embolization was technically successful in 68 (81%) of the 84 patients. Two early failures were associated with venous spasm provoked by technical inexperience, while difficulties in the remainder were caused by anomalous venous anatomy. In patients who had recurrent varicocele after previous ligation, venography showed incomplete ligation of collateral channels; 14 of 18 patients were successfully re-treated by embolization. The sperm concentration improved significantly in 83% of patients undergoing embolization and in 63% of those surgically ligated. Patients who underwent both procedures expressed a strong preference for embolization.
CONCLUSION: In centres where there is a skilled interventional radiologist, embolization is an effective alternative to surgical ligation of varicocele. Carried out under local anaesthesia as an out-patient procedure, it is cost-effective, associated with minimal morbidity and most patients are able to return to normal daily activities immediately.

Entities:  

Mesh:

Year:  1997        PMID: 9352706     DOI: 10.1046/j.1464-410x.1997.00407.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  9 in total

1.  Current management of adolescent varicocele.

Authors:  D A Paduch; S J Skoog
Journal:  Rev Urol       Date:  2001

2.  Percutaneous varicocele embolization.

Authors:  J Robert D Beecroft
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

Review 3.  The role of testicular artery in laparoscopic varicocelectomy: a systematic review and meta-analysis.

Authors:  Xiaokang Qi; Kunpeng Wang; Guangchen Zhou; Zhen Xu; Junjie Yu; Wei Zhang
Journal:  Int Urol Nephrol       Date:  2016-03-12       Impact factor: 2.370

4.  Treatment of varicocele with reference to age: a retrospective comparison of three minimally invasive procedures.

Authors:  S Beutner; M May; B Hoschke; C Helke; M Lein; J Roigas; M Johannsen
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

5.  Percutaneous retrograde varicocele embolisation using tungsten embolisation coils: a five year audit.

Authors:  S R Keoghane; L Jones; M P Wright; J Kabala
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

6.  Recurrent varicoceles: causes and treatment using angiography and magnification assisted subinguinal varicocelectomy.

Authors:  Kyung Hyun Moon; Suk Ju Cho; Kun Suk Kim; Seonghun Park; Sungchan Park
Journal:  Yonsei Med J       Date:  2012-07-01       Impact factor: 2.759

7.  Surgical or radiological treatment for varicoceles in subfertile men.

Authors:  Emma Persad; Clare Aa O'Loughlin; Simi Kaur; Gernot Wagner; Nina Matyas; Melanie Rosalia Hassler-Di Fratta; Barbara Nussbaumer-Streit
Journal:  Cochrane Database Syst Rev       Date:  2021-04-23

Review 8.  Recurrent varicocele.

Authors:  Katherine Rotker; Mark Sigman
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

9.  Contribution to the Pathophysiology and Treatment of Varicoceles.

Authors:  Peter Vanlangenhove
Journal:  J Belg Soc Radiol       Date:  2018-02-09       Impact factor: 1.894

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.